Calls

The Joint Transnational Call (JTC) 2026 “Personalised Medicine for CARdiovascular, MEtabolic, and kidNey diseases” (acronym: CARMEN2026), co-funded by the European Union, will fund multinational, innovative research projects in personalised medicine (PM), which should bring together academic, clinical/public health and private research teams, thus enhancing the competitiveness in Europe and beyond in this field.

Read more

EP PerMed has launched its first research, innovation and technology call (RITC2026) for proposals on “Test and Demonstration of Multimodal Data Approaches for Personalised Medicine”, acronym “MultiPMData2026”. In total, 19 funding organisations participate in this call with an available budget of over 14.8 Mio. € (approx.).

Read more

EP PerMed will launch the Fast Track Programme 2026 on 2 December 2025, offering targeted support to accelerate the validation and adoption of innovative personalised medicine solutions. The programme helps early-stage innovations progress by at least one Technology Readiness Level through dedicated validation studies carried out together with specialised European validation centres.

Read more

Advancing Collaborative Implementation of Personalised Medicine Approaches in Healthcare

Read more

The Call is closed! The EP PerMed Fast Track Call closed in June 2025. Call statistics are available here. Introduction Personalised Medicine (PM) represents a paradigm shift from a “one size fits all” approach to an optimised strategy for the prevention, diagnosis and treatment of disease for each individual, based on their unique characteristics, including…

Read more

EP PerMed has launched its second joint transnational call (JTC2025) for proposals on “Pharmacogenomic strategies for personalised medicine approaches (PGxPM2025)”. In total, 35 funding organisations participate in this call with an available budget of over 36.5 Mio. € (approx.).

Read more

The purpose of this call is to support the provision and development of educational content for healthcare professionals on the implementation of personalised medicine. Submission The objective of this Call is to provide subgrant funding to support the provision and development of educational content aimed at healthcare professionals (HCPs) in the implementation of personalised medicine…

Read more

Introduction Personalised Medicine (PM) represents a paradigm shift from a “one size fits all” approach to an optimised strategy for the prevention, diagnosis and treatment of disease for each individual, based on their unique characteristics, including biological features (e.g., phenotype, endotype, genotype), as well as lifestyle and environmental factors. Accordingly, PM puts the patient at…

Read more

Eight outstanding projects were selected for the EP PerMed Fast Track Validation Programme, an initiative designed to accelerate the development, validation, and adoption of innovative personalised medicine (PM) solutions across Europe. Call Announcement & Projects The call documents of the EP PerMed Fast Track Validation Programme were published on 10 December 2024. The call is…

Read more

Networking opportunity for previously funded projects in personalised medicine Rationale for organising Networking Support Calls EP PerMed’s rationale for organising Networking Support Calls (NSC) is to encourage networking in the field of personalised medicine (PM) and thereby stimulating the translation and implementation of research outcomes into clinical practice. The vision of EP PerMed, as described…

Read more

The European Partnership for Personalised Medicine (EP PerMed) Joint Transnational Call for Proposals 2024 (JTC2024) marks a significant step in aligning strategies and advancing collaborative research efforts in the field of personalised medicine (PM) between different countries and European national regions. Aiming to foster innovation and reinforce the competitiveness of European research, the call brought…

Read more